Editor's key points † Steroids have beneficial effects on some aspects of postoperative recovery. † There is limited evidence as to the optimal dose of steroid. † This study demonstrates a dose-response effect of dexamethasone on the quality of recovery after laparoscopic gynaecological surgery. † Dexmethasone (0.1 mg kg 21 )
The Quality of Recovery 40 questionnaire (QoR-40) is a multidimensional instrument that was specifically developed and validated to evaluate the health status of patients after anaesthesia and surgery. 9 It can be particularly useful when an intervention affects various aspects of patient recovery, as is the case for corticosteroids such as dexamethasone. The purpose of this study was to evaluate the dose-dependent effects of dexamethasone on the quality of recovery, postoperative airway morbidity, and opioid analgesic use after ambulatory gynaecological surgery.
Methods
This study was a prospective, randomized, double-blind placebo controlled trial. Clinical trial registration for this study can be found at www.clinicaltrials.gov; registration identified: NCT01052038. Study approval was obtained from the Northwestern University Institutional Review Board, and written informed consent was obtained from all the study participants. Eligible subjects were ASA physical status I and II females undergoing outpatient gynaecological laparoscopy. Patients with a history of recent respiratory tract infection (,1 month), current use of an opioid analgesic or corticosteroid, pregnancy, or anticipated difficult airway were not enrolled. Reasons for exclusion from the study after study drug administration included: difficult airway defined by more than two laryngoscopic attempts by the attending anaesthesiologist and conversion from a laparoscopic to an open laparotomy. A bedside airway examination was performed and the Mallampati classification was recorded. Subjects were randomized using a computergenerated table into three groups: saline, dexamethasone 0.05 mg kg 21 , and dexamethasone 0.1 mg kg 21 . Group assignments were sealed in sequentially numbered opaque envelopes that were opened by a research nurse not involved with the subjects' care. The study drug was administered in 100 ml of normal saline as an infusion over 10 min, when the patient was in the preoperative holding area. The anaesthesia care team was blinded to group allocation. All subjects were premedicated with 0.04 mg kg 21 intravenous (i.v.) midazolam. Propofol 1-2 mg kg 21 was administered for anaesthesia induction, a remifentanil infusion (0.1 mcg kg 21 min 21 ) was begun, and rocuronium 0.6 mg kg 21 i.v. was administered to induce muscle paralysis. Subjects were ventilated via a face mask until disappearance of all twitches on the train-of-four (TOF) monitor (EZ Stim II, Life Tech, Stafford, TX, USA). Tracheal intubation was initially attempted by an anaesthesia resident physician or a certified registered nurse anaesthetist under supervision of an attending anaesthesiologist. The number of intubation attempts, total time to intubation, and the need for cricoid pressure to improve laryngoscopy grade were recorded. Anaesthesia maintenance was achieved using remifentanil, titrated to keep the mean arterial pressure within 20% of baseline, and sevoflurane titrated to bispectral index (Aspect Medical System Inc., Norwood, MA, USA) between 40 and 60. Additional doses of rocuronium were administered to maintain the TOF between 1 and 3 twitches. During maintenance, patients received a mixture of air and oxygen to keep FI O 2 between 0.4 and 0.6. All gases were delivered though a humidified circuit. All patients had an orogastric tube placed.
At the end of the procedure, at removal of the laparoscopic instruments, the remifentanil infusion was stopped and the patient received hydromorphone 10 mg kg 21 i.v.
Neuromuscular blockade was antagonized using neostigmine 0.05 mg kg 21 and glycopyrrolate 0.01 mg kg 21 . Patients also received ketorolac 30 mg i.v., ondansetron 4 mg, and metoclopramide 10 mg before the end of the procedure. Before extubation, the subject's mouth was suctioned with a 14 French soft suction catheter and the presence of blood in the aspirate was noted. Subjects were extubated when they were able to perform a 5-s head lift and follow verbal commands.
In the post-anaesthesia recovery room, subjects were asked to rate their pain upon arrival and at regular intervals on a 0-10 numeric rating scale (NRS) for pain, where 0 means no pain and 10 is the worst pain imaginable. Nausea and vomiting were also assessed at the same intervals and recorded as present or absent. Hydromorphone 0.2 mg i.v. was administered every 5 min to maintain an NRS pain score ,4 of 10. The time to first hydromorphone administration was recorded. Discharge readiness was assessed by using the Post Anesthesia Discharge Scoring System (PADSS), 10 scored every 15 min until patients met discharge criteria. At discharge, subjects were instructed to take ibuprofen 400 mg orally for mild pain (,4 of 10) or hydrocodone 10 mg plus paracetamol 325 mg for pain . 4 of 10 every 4 h as needed. Subjects were assessed at 1, 3, and 24 h after the procedure and were asked about the presence or absence of a sore throat and to rate pain related to the sore throat at rest and with swallowing using an NRS for pain (where 0 is no pain and 100 is the worst sore throat pain ever experienced by the patient). At 3 h after the surgery, they were also questioned regarding the presence of cough using a previously described 11 grading scale where 0¼no cough or scratchy throat, 1¼minimal scratchy throat or cough, 2¼ moderate cough similar to a cold, or 3¼severe cough, greater than a cold. The presence and severity of hoarseness was also evaluated as 0¼no evidence of hoarseness occurring any time since your operation, 1¼no evidence of hoarseness at the time of interview, but hoarseness was present previously, 2¼hoarseness at the time of interview, that was noted only by the patient, or 3¼hoarseness that was easily noted at the time of interview.
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Subjects were contacted 24 h after the procedure by an investigator unaware of group allocation and were asked about analgesic consumption and the QoR-40 questionnaire was administered (Table 1) . Perioperative data collected included subject's age, height, weight, American Society of Anaesthesiologist physical class, surgical duration, intraoperative remifentanil use, total i.v. fluids, and total amount of hydromorphone in PACU.
Effects of dexamethasone on quality of recovery after surgery The primary outcome measure was the global QoR-40 aggregate score. Global QoR-40 scores range from 40 to 200 for representing very poor to outstanding quality of recovery. The mean QoR-40 in female patients after anaesthesia and surgery has been reported to be 162, and the sample was estimated to detect a difference of 10 points in the quality of recovery among the dexamethasone and placebo groups. 9 A sample size of 34 per group was estimated for the three study groups to be compared. The total sample of 102 subjects achieves 81% power to detect differences among the means using an F-test and a one-way analysis of variance at a 0.05 significance level. The common standard deviation within a group was assumed to be 26. 9 To account for dropouts, 120 subjects were randomized. The sample size calculation was made using PASS version 8. 
Results
The details of the conduct of the study are shown in Figure 1 . One hundred and twenty subjects were randomized and 106 completed the study. Patients were enrolled consecutively from January 2010 through September 2010. Patient's baseline characteristics and surgical factors were not different among groups (Table 2 ). The median (IQR) global recovery score (QoR-40) 24 h after discharge in the dexamethasone 0.1 mg kg Responses to individual items of the QoR-40 in the physical comfort, emotional state, psychological support, and pain dimension that demonstrated differences among groups are shown in NRS pain scores and opioid consumption in the first hour in the recovery room did not differ among groups (Table 4) . Cumulative opioid consumption by discharge was lower in Effects of dexamethasone on quality of recovery after surgery the 0.1 mg kg 21 dexamethasone group compared with the dexamethasone 0.05 mg kg 21 group and saline groups.
The presence and intensity of sore throat at 1 h was similar among groups but both the incidence and severity of sore throat were less in the dexamethasone groups compared with saline at 3 and 24 h ( 
Discussion
The important finding of this study was the dose-dependent effect of dexamethasone on quality of recovery after outpatient gynaecological surgery. Data were compared using the Kruskal -Wallis and the multiple comparison Z-value test (Dunn's test) with Bonferroni correction.
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Effects of dexamethasone on quality of recovery after surgery importantly, opioid consumption in the first 24 h after discharge was reduced with dexamethasone 0.1 mg kg 21 .
A major determinant for discharge after ambulatory surgery is the quality of postoperative pain control. 12 In addition to the direct influence of pain on readiness to discharge, side-effects of opioid analgesics such as nausea, vomiting, sedation, and urinary retention can also delay discharge time. The dose-related effects of dexamethasone observed in this study have important clinical implications since practice guidelines for prevention of postoperative nausea and vomiting after ambulatory surgery favour the use of the 0.05 mg kg 21 dose. 4 Another factor that may delay discharge and prolong recovery room stay after ambulatory surgery is the presence of a sore throat since pain related to the sore throat could make patients reluctant to go home. 8 Dexamethasone 0.05 and 0.1 mg kg 21 reduced sore throat pain compared with saline at 3 h which may have contributed to a faster discharge process. The reduced airway morbidity at 24 h in the dexamethasone 0.1 mg kg 21 group compared with both dexamethasone 0.05 mg kg 21 and saline represents additional evidence of improved quality of recovery with this dose. Multimodal analgesic techniques are frequently used to improve postoperative pain management and reduce opioid-related side-effects. 13 14 Several strategies including i.v. local anaesthetics, non-steroidal anti-inflammatory drugs, paracetamol, and N-methyl-D-aspartic acid receptor antagonists have been demonstrated to be effective after outpatient surgery. 15 The effect of corticosteroids on postoperative analgesia has not been as consistently demonstrated, and this may represent the wide variation in dexamethasone dosage studied. Wu and colleagues reported lower pain scores in the immediate postoperative period on subjects receiving 5 mg dexamethasone for outpatient anorectal surgery compared with saline; 16 however, in patients undergoing sinus surgery, Al-Qudah and colleagues did not find a difference in postoperative pain scores when comparing 8 mg of dexamethasone with placebo. 17 Jokela and colleagues demonstrated that 10 and 15 mg of dexamethasone had opioid sparing effects after laparoscopic hysterectomy. 18 Likewise, Haval and colleagues demonstrated lower VAS scores at 24 h compared with placebo when 16 mg of dexamethasone was administered to patients undergoing outpatient breast surgery. 19 The results of the aforementioned studies together with the results of the current study suggest that the analgesic and opioid-sparing effect of dexamethasone varies with the dose of dexamethasone administered as well as the type of surgical procedure. We restricted our study to a single type of surgery, outpatient gynaecological laproscopy, and demonstrated that dexamethasone 0.1 mg kg 21 provided effective multimodal analgesia; however, we cannot generalize our finding to other surgical procedures. 20 Several studies in ambulatory patients have evaluated quality of recovery primarily as improvement in postoperative pain, nausea, and vomiting; 21 -23 however, this approach has limited significance when not adjusted for patient's level of activity, emotional status, and independence. In the current study, we used the QoR-40 questionnaire, 9 designed to measure patient's health status after surgery and anesthesia. 24 -26 In a review of postoperative recovery assessment measures after ambulatory surgery, the QoR-40 was the only test that fulfilled the criteria of: appropriateness, reliability, validity, responsiveness, precision, interpretability, acceptability, and feasibility. 27 The authors did note that the QoR-40 was not specifically designed for use in ambulatory surgery and therefore the clinical correlate of the change in global QoR-40 values such as those observed in this study are difficult to assess. The responsiveness of this instrument has been assessed in patients evaluated before and after surgery. 9 The calculated standardized response mean of 0.65 was suggested by the authors to represent sensitivity of the instrument to clinically significant changes. In a study of outcomes after cardiac surgery, a poorer quality of life at 3 months was found in subjects that had median QoR-40 global values 10 points less than those with higher QoR-40 values 3 days after cardiac surgery. 28 Days 1 and 3 QoR-40 values were highly correlated. Therefore, we believe that the differences found in QoR-40 in this study represent clinically significant improvement in recovery with dexamethasone compared with saline. Improved self-reported quality of recovery and reduced emetic symptoms at 24 h after discharge for dexamethasone 4 mg vs control after ambulatory laparoscopic cholecystectomy has previously been reported. 29 The QoR scale used in the aforementioned study was based on a 0-100 selfreported scale and did not evaluate the domains of recovery. Effects of dexamethasone on quality of recovery after surgery dose the effects of dexamethasone on the QoR-40 most likely reflect its antiemetic actions, but at 0.1 mg kg 21 analgesic and euphoric effects are likely to have contributed to the increase in QoR-40 scores. Patients might have the same level of analgesia assessed by visual analogue scale scores but cannot be compared in terms of quality of recovery if they are unable to resume normal daily activities. In the current study, dexamethasone 0.1 mg kg 21 produced better physical comfort score (nausea, vomiting, retching, sleep, ability to eat). They also had greater physical independence scores. The higher dexamethasone group not only had less pain but they were also more active 24 h after surgery. These finding have important economic implication when evaluating costs associated with ambulatory procedures. 30 The mechanism of the analgesic effect of dexamethasone is multifactorial. It has anti-inflammatory properties by inhibition of phospolipase-A 2 , cytokines production, and decreasing polymorphonuclear leucocyte function, suppresses the production of free oxygen radicals and nitric oxide by endothelial cells, 31 and reduces postoperative oedema. 32 We suspect that the anti-inflammatory effects of dexamethasone may be responsible for the reduced clinical symptoms of airway morbidity, since the acute inflammatory reaction produced by the presence of the tracheal tube or direct trauma to the airway mucosa are believed to be mechanisms for the development of postoperative sore throat after procedures requiring tracheal intubation. 33 -35 We administered dexamethasone before the patient was taken to the operating room rather than after induction of anaesthesia which is more commonly done in clinical practice. We did this to optimize the effect of dexamethasone (peak effect 45 min to 1 h) on the stress response during surgical incision and other stress generating portions of surgery especially during the short ambulatory procedures studied. Also, because dexamethasone can produce an excruciating perineal burning in 50-70% of patients, we administered the drug slowly over 10 min diluted in 50 ml of saline. 36 37 There are limitations to our study. We limited our study to only two doses of dexamethasone and did not evaluate potential side-effects of dexamethasone such as hyperglycaemia, wound healing, and susceptibility to infection. Prior studies have evaluated headache, dizziness, wound infection, and wound healing after dexamethasone use in laproscopic cholecystectomy and a meta-analysis of dexamethasone-related adverse effects did not find an increased risk of these adverse effects at doses of dexamethasone similar to those used in this study. 1 The incidence of wound infection and wound healing problems in clean laparoscopic procedures is extremely low and no antibiotic prophylaxis is given for these procedures. An examination of the charts of the subjects at the follow up visit with the surgeon revealed no reports of problems with wound healing or infection. We limited our study to a single type of surgery with limited amount of a somatic pain component; therefore, our results may not be generalizable to more extensive surgeries. In addition, although the groups were assigned by random allocation and surgical procedure estimates were similar for all cases, the dexamethasone 0.05 mg kg 21 group did have more pain ablation procedures, were slightly longer and required more intraoperative remifentanil on examination compared with the saline and dexamethasone 0.1 mg kg 21 group, which may have affected the findings of the study. There were, however, no differences in time to meet discharge criteria (P¼0.9), opioid consumption before discharge (P¼0.3), or global QoR-40 scores (P¼0.5) among the surgical procedure groups. The effects of the dexamethasone on quality of recovery observed in this study were in addition to the effects of ketorolac, metaclopramide, and ondansetron which were administered to all patients.
In conclusion, we demonstrated that 0.1 mg kg 21 of dexamethasone produced a better quality of recovery with less postoperative pain and better return to normal daily activities after outpatient gynaecological laproscopic surgery when compared with 0.05 mg kg 21 of dexamethasone and placebo. The higher dexamethasone dose also produced an opioid-sparing effect, which may be beneficial for improving recovery after ambulatory surgery.
